Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT)

v3.22.1
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) - USD ($)
Class A Common Stock
Common Stock
Class B Common Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020   $ 719 $ 24,281 $ (13,671) $ 11,329
Balance at the beginning (in shares) at Dec. 31, 2020   7,187,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Sale of private placement units to Sponsor in private placement, less allocation to derivative warrant liabilities $ 80   7,711,920   7,712,000
Sale of private placement units to Sponsor in private placement, less allocation to derivative warrant liabilities (in shares) 800,000        
Accretion of Class A ordinary shares subject to redemption     (7,736,201) (18,420,576) (26,156,777)
Net income       3,598,716 3,598,716
Balance at the end at Mar. 31, 2021 $ 80 $ 719   (14,835,531) (14,834,732)
Balance at the end (in shares) at Mar. 31, 2021 800,000 7,187,500      
Balance at the beginning at Dec. 31, 2021 $ 80 $ 719 0 (16,115,670) (16,114,871)
Balance at the beginning (in shares) at Dec. 31, 2021 800,000 7,187,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 0 $ 0 0 3,071,920 3,071,920
Balance at the end at Mar. 31, 2022 $ 80 $ 719 $ 0 $ (13,043,750) $ (13,042,951)
Balance at the end (in shares) at Mar. 31, 2022 800,000 7,187,500